Chapter 4: Genital tract infections, cervical inflammation, and antioxidant nutrients—assessing their roles as human papillomavirus cofactors

PE Castle, AR Giuliano - Jnci Monographs, 2003 - academic.oup.com
Cervical infections by approximately 15 human papillomavirus (HPV) types are the
necessary cause of cervical cancer and its immediate precursor lesions. However …

Chapter 12: Human papillomavirus technologies

T Iftner, LL Villa - Jnci Monographs, 2003 - academic.oup.com
Currently, human papillomavirus (HPV) DNA tests validated in large trials and
epidemiological studies are the hybrid capture second-generation (HC2) HPV DNA assay …

Recent observations on HIV type-1 infection in the genital tract of men and women

RW Coombs, PS Reichelderfer, AL Landay - Aids, 2003 - journals.lww.com
The ultimate success of strategies to prevent sexual transmission of HIV depends, in part, on
a better understanding of the virological and immunological mechanisms that define sexual …

Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus–like particles

D Nardelli-Haefliger, D Wirthner… - Journal of the …, 2003 - academic.oup.com
Background: In early-phase trials, a human papillomavirus 16 (HPV16) virus–like particle
(VLP) vaccine has been shown to be well tolerated, immunogenic, and protective against …

Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study

ME Scott, YB Shvetsov, PJ Thompson… - … journal of cancer, 2013 - Wiley Online Library
Mechanisms for the control and resolution of human papillomavirus (HPV) infection of the
cervix include the local production of cytokines, which control recruitment and function of …

[HTML][HTML] Infection and vaccine-induced HPV-specific antibodies in cervicovaginal secretions. A review of the literature

J Pattyn, S Van Keer, W Tjalma, V Matheeussen… - Papillomavirus …, 2019 - Elsevier
Background Human papillomavirus (HPV) infects and propagates in the cervical mucosal
epithelium. Hence, in addition to assessing systemic immunity, the accurate measurement of …

The strength of B cell immunity in female rhesus macaques is controlled by CD8+ T cells under the influence of ovarian steroid hormones

FX Lü, K Abel, Z Ma, T Rourke, D Lu… - Clinical & …, 2002 - academic.oup.com
To understand more clearly how mucosal and systemic immunity is regulated by ovarian
steroid hormones during the menstrual cycle, we evaluated the frequency of …

High levels of tumor necrosis factor—α and interleukin-1β in bacterial vaginosis may increase susceptibility to human immunodeficiency virus

K Sturm-Ramirez, A Gaye-Diallo, G Eisen… - The Journal of …, 2000 - academic.oup.com
Bacterial vaginosis (BV) was identified recently as a cofactor that promotes sexual
transmission of human immunodeficiency virus (HIV). This study was done to determine if …

A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection

S Longet, JT Schiller, M Bobst, P Jichlinski… - Journal of …, 2011 - Am Soc Microbiol
The available virus-like particle (VLP)-based prophylactic vaccines against specific human
papillomavirus (HPV) types afford close to 100% protection against the type-associated …

Randomized phase I: safety, immunogenicity and mucosal antiviral activity in young healthy women vaccinated with HIV-1 Gp41 P1 peptide on virosomes

G Leroux-Roels, C Maes, F Clement… - PloS one, 2013 - journals.plos.org
Mucosal antibodies harboring various antiviral activities may best protect mucosal surfaces
against early HIV-1 entry at mucosal sites and they should be ideally induced by …